Brugada ECG disclosed by acute malaria: is it all about fever and propofol?

Brugada syndrome is an electrical cardiac disease predisposing to ventricular arrhythmias in which typical electrocardiographic (ECG) features consist of nonischemic repolarization abnormalities in the right precordial leads V1-V3. The appearance of a Brugada-ECG pattern is increasingly observed in critically ill patients and is traditionally attributed to the effect of body temperature and/or drug modulation on cardiac ion channels (“acquired Brugada syndrome”). A patient with complicated malaria in whom Brugada-ECG abnormalities appeared in concomitance with fever and propofol administration is presented. The repolarization changes did not disappear until the patient’s clinical course improved.     

Brugada syndrome

Brugada syndrome is characterized by the right bundle branch block type electrocardiogram (ECG) with ST-segment elevation and ventricular fibrillation (Vf) attack in patients without obvious heart disease. Its background is considered to be the genetic Na channelopathy. The coved type is a typical morphology and is classified into type 1 in the European Society of Cardiology (ESC). In general, the coved type and the saddel-back type (type 2, 3 in the ESC) are interchangeable, and the latter is more frequently detected clinically. For diagnosis of the Brugada syndrome, confirmation of the type 1 morphology is needed. Administration of Na channel blocker, pilsicainide, is a sensitive test for confirmation of the type 1. When the type 1 has one of 7 items recommended by the ESC, the patient is diagnosed with Brugada syndrome. ECG finding alone is classified into patient with Brugada type ECG. As there is no reliable medical treatment, implantation of a cardioverter defibrillator is indicated in patients with Brugada syndrome, and observation alone in those with Brugada type ECG.     

Perioperative management of patients with Brugada syndrome

In 1992, Brugada et al. first reported eight cases of ventricular fibrillation, in which ST-segment abnormalities in leads V1 through V3 along with T-wave inversion, and complete or incomplete right bundle branch block were observed on the standard 12-leads ECG. Since then, this syndrome has been widely recognized as one of important diseases that can produce sudden death in middle aged healthy males. The ECG morphology of Brugada syndrome is believed to be caused by either an accentuation of the notch in the early phase of the action potential or loss of the action potential dome in the epicardium. Mechanisms of ventricular fibrillation in this syndrome are still unclear, but thought to be phase II re-entry caused by dispersion of the action potentials. It has been shown that mutations of the human cardiac Na+ channel gene (SCN5A) underlie multiple cardiac diseases including Brugada syndrome. In fact, single amino acid substitution within the SCN5A coding region can evoke a cardiac rhythm behavior. In this review, we will focus on recent progress of basic and clinical research of Brugada syndrome and perioperative management of this syndrome.     

General anesthesia for patients with Brugada syndrome. A report of six cases

PURPOSE: To review six cases of Brugada syndrome presenting for insertion of a cardioverter-defibrillator under general anesthesia. CLINICAL FEATURES: All patients had a history of syncope, ST segment elevation in the right precordial lead of the electrocardiogram (ECG) which became prominent after a pilsicainide challenge test. Routine monitors, right precordial lead of the ECG and an external defibrillator were installed prior to anesthesia. We administered propofol/midazolam for induction, and propofol/sevoflurane combined with fentanyl for maintenance of anesthesia. Atropine and ephedrine were administered to decrease vagal tone. No ECG change or arrhythmia was observed perioperatively. After the successful implantation of the defibrillator, all patients were discharged without any adverse event. CONCLUSION: By avoiding agents or conditions that may exacerbate Brugada syndrome during anesthesia, we were able to manage the patients uneventfully for implantation of a cardioverter-defibrillator.     

Anesthetic management of two patients with Brugada-type ECG and of different clinical severity

Brugada syndrome is an arrhythmia syndrome characterized by typical electrocardiogram (Brugada-type ECG) and development of ventricular fibrillation (Vf) without any distinct structural heart diseases. The essential goal in the management of Brugada syndrome is to avoid the development of Vf. However, there has been no established consensus on pre-operative risk assessment of patients with Brugada-type ECG. We recently experienced two cases of anesthetic managements for patients with Brugada-type ECG. Based on these experiences and recent cardiological progress on the risk stratification of Brugada syndrome, we thoroughly discuss on the peri-operative managements for patients with Brugada-type ECG.     

Case of ventricular fibrillation in patients with brugada type electrocardiogram during surgery

We described a case of ventricular fibrillation in patients with Brugada type electrocardiogram (ECG) during surgery. A 63-year-old man underwent lung lobectomy under combined general and epidural anesthesia. His preoperative ECG showed Brugada type, but he was asymptomatic and did not have a family history of sudden death. Anesthesia was induced using propofol, vecuronium and fentanyl, and maintained using propofol and lidocaine via epidural catheter. One hour into operation, ventricular fibrillation developed. After cardiac compression in a few seconds, sinus rhythm was restored and blood pressure was elevated. When the wound was sutured, ventricular fibrillation occurred again. Defibrillation was attempted immediately and sinus rhythm was restored. We diagnosed coronary spastic angina after acetylcholine challenge test. Previous report describes that the incidence of vasospasm in Brugada type ECG cases is relatively higher than those with the normal ECG. In addition, ventricular fibrillation might be induced by local anesthetics because these agents were administrated 10 minutes before the few events and balance of autonomic nervous system was changed. We conclude that strict monitoring and immediate treatment for ventricular fibrillation are important for anesthetic management in asymptomatic patient with Brugada type ECG.     

Preoperative evaluation and anesthetic management of a patient with Brugada syndrome-like ECG

Brugada syndrome has been known as one of the causes of sudden death due to ventricular fibrillation. We experienced anesthetic management of seven patients with ECG showing Brugada syndrome before surgery, even though they had no symptoms nor family history. All of them showed no problems through-out the operation. Such patients are often untreated, but they have the risks of cardiac accidents such as ventricular fibrillation or sudden death. For preoperative evaluation of patients with Brugada syndrome-like ECG, it is important to ask them their experience of syncope and family history. Ultrasonic cardiography and Holter ECG recording should be done. External defibrillator should be prepared and parasympathetic dominant condition must be avoided during the anesthetic management.     

Cardiac Arrest with “Pseudo‐Brugada” ECG Pattern in the Setting of a Coronary Artery Anomaly

Abstract A 36‐year‐old Hispanic man with no prior cardiac history presented with chest pain and then ventricular fibrillation requiring defibrillation after a physical altercation. His ECG on presentation to the emergency room was suggestive of Brugada syndrome, which later normalized. Cardiac catheterization revealed anomalous origin of right coronary artery from the left coronary cusp (coursing between the pulmonary artery and the aorta) for which he underwent surgical reimplantation, and subsequent pharmacological challenge test did not provoke reappearance of a Brugada ECG pattern. A review of literature on Brugada syndrome and anomalous origin of the coronary arteries is presented. (J Card Surg 2010;25:614‐617)     

Anesthetic management of a patient with Brugada syndrome

Brugada syndrome is characterized by right bundle-branch block, ST elevation in leads V 1 through V 3 and normal QT interval. Ventricular fibrillation frequently occurs in patients with Brugada syndrome. There have been few reports of anesthetic management of Brugada patients. We managed a 47-year-old man with Brugada syndrome, who underwent hemilaminectomy under general anesthesia, without untoward cardiovascular events. Potential problems in anesthetic management of patients with Brugada syndrome are also discussed.     

The use of somtaosensory evoked potential (SSEP) and motor evoked potential (MEP) monitoring in a patient with Brugada syndrome

IntroductionWe report on the use of Somastosensory Evoked Potential (SSEP) and Motor Evoked Potential (MEP) monitoring in a patient with Brugada syndrome.ObjectivesThe concern in this case was that the amount of current/voltage generated by SSEP/MEP might trigger arrhythmias in a patient with underlying Brugada syndrome.MethodsA 42 year-old male patient with Brugada syndrome underwent excision of an intramedullary tumour with the use of SSEP and MEP monitoring. Preoperatively, he was not on antiarrhythmic medication, nor had an Implantable Cardioverter Device (ICD) in-situ.ResultsThe patient remained stable & in sinus rhythm throughout the operation and was successfully extubated postoperatively.ConclusionThis case report indicates that SSEP/MEP monitoring may be used in patients with Brugada syndrome.     

Cardiac surgery and Brugada syndrome: operative considerations

Brugada syndrome is an uncommon arrhythmic disease due to abnormality in myocardial transmembrane sodium channels and is associated with sudden death due to ventricular arrhythmias. We report our strategy and highlight precautions to reduce the risk of perioperative arrhythmias in a patient with Brugada pattern who underwent successful coronary artery bypass grafting.     

Anesthetic management for patients with Brugada syndrome

Brugada syndrome should not be neglected in terms of anesthetic management because its perioperative autonomic imbalance may cause ventricular fibrillation and sudden cardiac arrest. Diagnosis of Brugada syndrome is easily made by unique electrocardiographic pattern of right bundle branch block and ST segment elevation in the right precordial leads. Thus the number of patients with Brugada syndrome for anesthetic management tends to increase. We review current concept of anesthetic management for patients with Brugada syndrome including fourteen cases in our institution, two out of which developed VF during operation.     

General anaesthesia in a patient affected by Brugada syndrome

This case report describes an asymptomatic patient with positive familiar anamnesis of Brugada syndrome (BrS) who elected to undergo surgery. The anaesthesiological technique using propofol, fentanyl, atracurium, air/oxygen did not induce any electrocardiographic alteration during the operation; the intraoperation use of a biphasic defibrillator was critical here. The cerebral state index and adhesive plaques connected with a biphasic defibrillator having PM capabilities allowed us to monitor the operation and continually assess the patient's cardiac stability. Afterwards, the patient was transferred to the intensive care unit and was monitored for 24 hours. This anesthesiological technique was performed in place of ARL, which the patient refused.     

The anaesthetic management of a parturient with polymorphic catecholamine-sensitive ventricular tachycardia

Polymorphic catecholamine-sensitive ventricular tachycardia is an uncommon but potentially life-threatening condition. There are few reports of this condition in pregnancy. It is one of five types of polymorphic ventricular arrhythmia, the others being long-QT syndrome, short coupled variant of torsade de point malignant disease, idiopathic ventricular fibrillation with normal ECG and Brugada syndrome. Exercise and stress can precipitate ventricular tachyarrhythmias in patients with polymorphic catecholamine-sensitive ventricular tachycardia and it is important to avoid increases in plasma catecholamine levels. We report on the anaesthetic management of a parturient with this condition, for elective caesarean section and discuss the stress response in parturients receiving regional and general anaesthesia.     

Surgically Treated Primary Lung Cancer Associated with Brugada Syndrome: Report of a Case

A 71-year-old man with primary lung cancer associated with Brugada syndrome was safely oper-ated on following the placement of an implantable cardioverter defibrillator (ICD). During examinations for Brugada syndrome, a tumor in the apicoposterior segment of the left lung was incidentally detected by chest computed tomography. Following the implantation of an ICD, surgical treatment of the left lung tumor was scheduled. A lung biopsy was thoracoscopically performed and adenocarcinoma was diagnosed based on a frozen section analysis. A left upper lobectomy with lymph node dissection was performed through a standard posterolateral thoracotomy. Ventricular fibrillation, which occurred during the night of the first day following surgery, was successfully managed by the ICD. Received: September 29, 2000 / Accepted: May 15, 2001     

Brugada-type electrocardiographic pattern induced by epidural bupivacaine

IMPLICATIONS: In this case report, we describe the postoperative occurrence of electrocardiogram changes suggestive for the Brugada syndrome in a patient receiving a continuous epidural bupivacaine infusion. After withdrawal of bupivacaine, the electrocardiogram changes were reversible. The patient's history was unremarkable except for an incomplete right bundle branch block. We conclude that local anesthetics, particularly bupivacaine, have the potential to induce serious arrhythmias in patients with Brugada syndrome.     

A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis.

Mycophenolate mofetil (MMF) is increasingly used for prevention of allograft rejection and to treat immune disorders. We report the development of an acute inflammatory syndrome in two patients with Wegener's granulomatosis after MMF was introduced, because of persistent renal and systemic disease activity despite cyclophosphamide treatment. Within 1 week both patients developed an acute inflammatory syndrome, characterized by fever, arthralgias and muscle pain. No infection could be detected and no indications for increased Wegener's activity were present. MMF was stopped resulting in a rapid and complete resolution of the syndrome. A rechallenge with 2 g of MMF in the second patient resulted in a relapse of the syndrome within 4 days. There was an association between symptoms and increased levels of mycophenolic acid (MPA) acyl glucuronide and serum interleukin-6, suggesting the induction of inflammatory cytokines by MPA acyl glucuronide as the cause of the syndrome. Therefore, special attention should be given to side effects such as fever, arthralgias and muscle pain when treating patients with Wegener's granulomatosis during the active phase. Because this side effect of MMF may also occur after solid organ transplantation and in other immune disorders, pharmacokinetic profiling of MPA and MPA acyl glucuronide is needed in future studies with MMF.     

Extracardiac Minimal Invasive Implantation of Cardioverter Defibrillator in Young Children

Implantable cardioverter defibrillator (ICD) placement in young children remains a challenge due to devicepatient size mismatch and the important choice between an endovenous or an epicardial approach for lead implantation. We treated three children, with respectively Long QT-syndrome, Brugada syndrome and Brugada syndrome with sick sinus syndrome, ranging from 9 months to 7 years with a subxyphoidal ICD and extracardiac lead implantation by minimally invasive techniques. In all cases the thresholds were excellent. The devices could be properly placed in the preperitoneal space without discomfort to the patients. The clinical course was uneventful and results were excellent.     

Early postoperative myocardial morbidity in patients with coronary artery disease undergoing major non-cardiac surgery: correlation with perioperative ischaemia

As a part of a study assessing early postoperative myocardial morbidity in 50 patients with active coronary artery disease undergoing major non-cardiac surgery, the ECG was monitored continuously for 24 hr after the onset of anaesthesia, using a frequency modulated (FM) Holter monitor. Concurrent automated blood pressure and pulse were measured non-invasively at three-minute intervals during anaesthesia and subsequently at five-minute intervals. Thirty patients were monitored with two-site ECG recordings, from modified V1 and V5 (Group A). Twenty patients had seventeen-site ECG monitoring, multiplexing a four by four array of precordial electrodes onto one channel of the frequency modulated recorder (Group B). Tapes were analyzed for noise, supraventricular and ventricular dysrythmias, runs of tachy- and bradycardia, and ST segment changes. These data were correlated with serial standard 12-lead ECGs and CK-MB assay in the 72 hr after surgery. Seven tapes from Group A could not be analyzed. Change (greater than 1 mm) on ST monitoring from both Groups A (14/23), B (14/20), correlated with serial 12-lead ECG and/or CK-MB changes. The majority of first ST change 19/28 (70%) occurred after anaesthesia. In 14/28 (50%) ST change occurred during episodes of tachycardia and elevated blood pressure (greater than 20% above baseline). Nine patients (9/23) in Group A had no ST change; however, six had serial 12-lead ECG and/or CK-MB changes. Six patients (6/20) in Group B had no ST changes, and none of these patients had any change of serial 12-lead ECGs or CK-MB assay. No patient complained of chest pain during the Holter monitoring period. Continual monitoring of heart rate and blood pressure and accurate ST monitoring are essential to detect and treat perioperative myocardial ischemia. A multiple-lead precordial system is substantially more sensitive than traditional two-lead ECG holter monitoring in detecting myocardial ischaemia.     

Extracardiac minimal invasive implantation of cardioverter defibrillator in young children

Implantable cardioverter defibrillator (ICD) placement in young children remains a challenge due to device-patient size mismatch and the important choice between an endovenous or an epicardial approach for lead implantation. We treated three children, with respectively Long QT-syndrome, Brugada syndrome and Brugada syndrome with sick sinus syndrome, ranging from 9 months to 7 years with a subxyphoidal ICD and extracardiac lead implantation by minimally invasive techniques. In all cases the thresholds were excellent. The devices could be properly placed in the preperitoneal space without discomfort to the patients. The clinical course was uneventful and results were excellent.